Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pilon

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 6, 2005
Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profilesBeth N Shashikant, Thomas L Miller, Richard W Welch, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 7, 2006
Effects of recombinant Clara cell secretory protein (rhCC10) on inflammatory-related matrix metalloproteinase activity in a preterm lamb model of neonatal respiratory distressThomas L Miller, Beth N Shashikant, Aprile L Pilon, et al.
Biology of the Neonate|October 8, 2005
Effects of an intratracheally delivered anti-inflammatory protein (rhCC10) on physiological and lung structural indices in a juvenile model of acute lung injuryThomas L Miller, Beth N Shashikant, Aprile L Pilon, et al.
Journal of Cellular Physiology|February 3, 2006
Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectinGiovanni Antico, Mark W Lingen, Antonella Sassano, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 12, 2013
Preclinical evaluation of human secretoglobin 3A2 in mouse models of lung development and fibrosisYan Cai, Melissa E Winn, John K Zehmer, et al.
Elife|December 12, 2018
A novel pathway of LPS uptake through syndecan-1 leading to pyroptotic cell deathShigetoshi Yokoyama, Yan Cai, Miyuki Murata, et al.
American Journal of Perinatology|October 9, 2008
Recombinant human Clara cell secretory protein treatment increases lung mRNA expression of surfactant proteins and vascular endothelial growth factor in a premature lamb model of respiratory distress syndromeMarla R Wolfson, Vicky L Funanage, Susan M Kirwin, et al.
Pediatric Research|May 16, 2019
The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurityJonathan M Davis, Aprile L Pilon, Jeffrey Shenberger, et al.
Pediatric Research|March 19, 2005
The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndromeCarolyn R Levine, Ira H Gewolb, Kristen Allen, et al.
Journal of Animal Science|December 23, 2008
Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive materialR G L Murphy, J A Scanga, B E Powers, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 6, 2005
Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profilesBeth N Shashikant, Thomas L Miller, Richard W Welch, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 7, 2006
Effects of recombinant Clara cell secretory protein (rhCC10) on inflammatory-related matrix metalloproteinase activity in a preterm lamb model of neonatal respiratory distressThomas L Miller, Beth N Shashikant, Aprile L Pilon, et al.
Biology of the Neonate|October 8, 2005
Effects of an intratracheally delivered anti-inflammatory protein (rhCC10) on physiological and lung structural indices in a juvenile model of acute lung injuryThomas L Miller, Beth N Shashikant, Aprile L Pilon, et al.
Journal of Cellular Physiology|February 3, 2006
Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectinGiovanni Antico, Mark W Lingen, Antonella Sassano, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 12, 2013
Preclinical evaluation of human secretoglobin 3A2 in mouse models of lung development and fibrosisYan Cai, Melissa E Winn, John K Zehmer, et al.
Elife|December 12, 2018
A novel pathway of LPS uptake through syndecan-1 leading to pyroptotic cell deathShigetoshi Yokoyama, Yan Cai, Miyuki Murata, et al.
American Journal of Perinatology|October 9, 2008
Recombinant human Clara cell secretory protein treatment increases lung mRNA expression of surfactant proteins and vascular endothelial growth factor in a premature lamb model of respiratory distress syndromeMarla R Wolfson, Vicky L Funanage, Susan M Kirwin, et al.
Pediatric Research|May 16, 2019
The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurityJonathan M Davis, Aprile L Pilon, Jeffrey Shenberger, et al.
Pediatric Research|March 19, 2005
The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndromeCarolyn R Levine, Ira H Gewolb, Kristen Allen, et al.
Journal of Animal Science|December 23, 2008
Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive materialR G L Murphy, J A Scanga, B E Powers, et al.
Pageof 4